did serena williams use glp-1 is opening up about her experience with medications. The 43-year-old tennis star has lost 31 pounds on the drug Zepbound, a type of medication typically prescribed for diabetes and Serena Williams paid endorsement for

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic poly-peptide (GIP, previously known as gastric inhibitory polypeptide) are key incretin

Should you buy the stock now?

Avoid common mistakes that can cause discomfort

The rise of GLP-1 therapies has transformed patient care and created a new level of complexity in safety surveillance

Among people with pre-existing SUDs, initiation of GLP-1 receptor agonists was associated with reduced risk of SUD related emergency department visits (0.69 (0.61 to 0.78), NRD 8.92 (11.59 to 6.25)), SUD related hospital admissions (0.74 (0.65 to 0.85), NRD 6.23 (8.73 to 3.74)), and SUD related mortality (0.50 (0.32 to 0.79), NRD 1.52 (2.32 to 0.72)), and drug overdose (0.61 (0.42 to 0.88), NRD 1.49 (2.43 to 0.55)) and suicidal ideation or attempt (0.75 (0.67 to 0.83), NRD 9.95 (13.14 to 6.77))

This product does not contain GLP-1 receptor agonists and does not promote weight loss